GlassScriptPhysician profile
Kathleen A Lyons
NPI 1699868885
$824.53
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $46.91 · 2022: $23.93 · 2023: $648 · 2024: $106.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $754.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $753.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $125.24 | 2021-2023 | |
| Otsuka America Pharmaceutical, INC. | $93.53 | 2023 | Rexulti, Nuedexta, Abilify Maintena |
| Alkermes, INC. | $87.93 | 2022-2023 | Aristada, Lybalvi |
| Abbvie INC. | $80.44 | 2023-2024 | |
| Neurocrine Biosciences, INC. | $71.54 | 2023-2024 | Ingrezza |
| Corium, LLC | $70.86 | 2023-2024 | Azstarys |
| Axsome Therapeutics, INC. | $53.29 | 2023-2024 | Auvelity |
| Janssen Pharmaceuticals, INC | $43.10 | 2023 | Invega, Spravato |
| Bioxcel Therapeutics, INC. | $38.00 | 2023 | Igalmi |
| Lundbeck LLC | $34.06 | 2023 | Rexulti |
| Takeda Pharmaceuticals U.S.A., INC. | $32.00 | 2023 | Trintellix |
| Almatica Pharma LLC | $24.56 | 2023 | Loreev Xr |
| Merck Sharp & Dohme LLC | $23.67 | 2023 | Belsomra |
| Ironshore Pharmaceuticals INC. | $16.49 | 2023 | Jornay Pm |
| Sage Therapeutics, LLC | $14.95 | 2024 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $14.87 | 2023 | Qelbree |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kathleen Lyons listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.